Plunkett Research Online: Lineage Cell Therapeutics Inc

LINEAGE CELL THERAPEUTICS INC (LCTX:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Line.....



Lineage Cell Therapeutics Inc
Ticker: LCTX
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 442-287-8990
Fax:
Address: 2173 Salk Avenue
Suite 200
Carlsbad, CA 92008 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Surgical
Biotechnology
Cell Therapy Development
Clinical Testing
Cell Replacement
Contacts Description
Brian Culley CEO/Director/President
Kevin Cook CFO/Chief Accounting Officer
See More
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Line.....See More See More

Auditor: WithumSmith+Brown, PC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
OpRegen
OPC1
VAC2
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: